Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORETreatment for subclinical infectious bovine mastitis in lactating cows due to Streptococcus agalactiae and penicillin-sensitive Staphylococcus aureus.
LEARN MOREFor the vaccination of healthy 18-day old chicken embryos or chickens 1-day of age against standard and variant infectious bursal disease.
LEARN MORE